obesity drug news today glp-1 september 29 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio KFF Health Tracking Poll: Prescription

Because of an increased risk of diabetic ketoacidosis ketone monitoring in patients with type 1 diabetes and in others at risk for ketoacidosis (patients with type 2 diabetes on insulin therapy) should be considered, particularly when precipitating conditions for diabetic ketoacidosis occur such as acute febrile illness, reduced caloric intake, ketogenic diet, surgery, insulin dose reduction, volume depletion, or alcohol abuse

But vitamins, minerals, amino acids, and essential nutrients also come from food

Contrave (naltrexone/bupropion) Approved - An oral medication combining an opioid antagonist and an antidepressant

GLP-1 is being developed for use in various diseases outside obesity

Though they have historically been used to help patients manage their type 2 diabetes, Semaglutide GLP-1 injections have recently become approved for use as part of medical weight loss treatments

Biotinylated antibodies were then added to each membrane and incubated overnight followed by a final incubation with a streptavidin-conjugated fluorescent label to detect the cytokine expression